Dexibuprofen

右布洛芬

Report date: 2024/03/20 17:17:03
NME

Base Information

Drug NameDexibuprofen
Drug Alias Name右旋布洛芬DaxfenS-布洛芬Movone(S)-(+)-Ibuprofen +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsAcute PainPainFever +[5] 
Global Approved IndicationsPainFeverInflammation
Approved Indications in ChinaPainFever
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryUnited StatesUnited KingdomBrazil +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGebro Pharma GmbhHubei Biocause Heilen Pharmaceutical Co Ltd
Inactive CompaniesAponia Laboratories IncApsen Farmaceutica S/ABeijing Jiacheng Biomedical Technology Development Co Ltd +[9] 
Active IndicationsPainFeverInflammation
Inactive IndicationsAcute PainMyalgia

Other Information

ATC CodeM01AE14
Related LinksWikipediaDrugBankKEGG